|
|
Volumn 3, Issue 4, 2001, Pages 481-489
|
|
The CARE-HF study (cardiac resynchronisation in heart failure study): Rationale, design and end-points
a,b
|
|
Author keywords
ACE inhibitors; Beta blockers; Cardiac (atrio bi ventricular) resynchronisation; Cardiac dyssynchrony; CARE HF trial
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ARTICLE;
ARTIFICIAL HEART PACEMAKER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEVICE;
HEART FAILURE;
HEART LEFT VENTRICLE FAILURE;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
METHODOLOGY;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT PLANNING;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CAUSE OF DEATH;
ECHOCARDIOGRAPHY;
ELECTROCARDIOGRAPHY;
FEMALE;
GREAT BRITAIN;
HEART FAILURE, CONGESTIVE;
HEART-ASSIST DEVICES;
HUMANS;
MALE;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
REFERENCE VALUES;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 0034893807
PISSN: 13889842
EISSN: None
Source Type: Journal
DOI: 10.1016/S1388-9842(01)00176-3 Document Type: Article |
|
Times cited : (298)
|
|
References (14)
|
